FDA recall D-1384-2012

Teva Pharmaceuticals USA, Inc. · Class III · drug

Product

Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.

Reason for recall

Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2012-04-23
Report date
2012-06-27
Termination date
2013-04-23
Voluntary/Mandated
Voluntary: Firm initiated
Location
Sellersville, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1384-2012